Abstract
Greater understanding of development and dissipation of acute tolerance to nicotine may help explain temporal patterns of nicotine self-administration in smokers. The time course of dissipation of acute tolerance to nicotine was examined in 16 smokers (8M, 8F) participating in four sessions differing on pretreatment exposure or time interval prior to nicotine (20 µg/kg) challenge: placebo 30 min before, or nicotine (20 µg/kg) 30, 60, or 120 min before challenge. Nicotine and placebo were administered by measured-dose nasal spray. The measurement battery consisted of subjective, cardiovascular, thermal pain detection, and behavioral performance measures. Results demonstrated significant acute tolerance (i.e. smaller responses to nicotine challenge following nicotine versus placebo pretreatment) for most subjective measures and for heart rate. Acute tolerance dissipated with lengthening inter-dose interval for two subjective measures, dose strength and arousal, but there was no tolerance dissipation for other measures. In contrast, nicotine pretreatment resulted in acute sensitization of finger temperature (vasoconstriction) response, which dissipated with lengthening interval. No acute tolerance was observed for thermal pain detection or performance measures. These findings demonstrate that acute tolerance develops quickly to some subjective and cardiovascular effects of nicotine. However, acute tolerance to most effects did not dissipate over 2 h, suggesting that, following acute tolerance development during initial exposure, most smokers generally obtain similar magnitude of effects from each subsequent nicotine exposure (i.e. cigarettes smoked later in the day).
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Benowitz NL, Porchet H, Jacob P (1990) Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford University Press, New York, pp 112–157
Chornock WM, Stitzer ML, Gross J, Leischow S (1992) Experimental model of smoking re-exposure: effects on relapse. Psychopharmacology 108:495–500
de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75:134–143
de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol Biochem Behav 33:205–213
Epstein LH, Caggiula AC, Perkins KA, McKenzie SJ, Smith JA (1991) Conditioned tolerance to the heart rate effects of smoking. Pharmacol Biochem Behav 39:15–19
Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235–241
Fischman MW, Foltin RW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563–1570
Frederiksen LW, Frazier M (1977) Temporal distribution of smoking. Addict Behav 2:187–192
Hatsukami DK, Pickens RW, Svikis DS, Hughes JR (1988) Smoking topography and nicotine blood levels. Addict Behav 13:91–95
Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1–12
Herning RI, Jones RT, Benowitz NL, Mines AH (1983) How a cigarette is smoked determines blood nicotine levels. Clin Pharmacol Ther 33:84–90
Huitema B (1980) Analysis of covariance and alternatives. Wiley, New York
Jacob P, Wilson M, Benowitz NL (1981) Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr 222:61–70
Jones RT, Farrell TR, Herning RI (1978) Tobacco smoking and nicotine tolerance. In: Krasnegor NA (ed) Self-administration of abuse substances: methods for study. US Govt Printing Office, Washington DC, pp 202–208
Kalant H, Khanna JM (1990) Methods for the study of tolerance. In: Adler M, Cowan A (ed) Modern methods in pharmacology, vol. 6. Wiley-Liss, New York, pp 43–66
Kozlowski LT, Herman CP (1984) The interaction of psychosocial and biological determinants of tobacco use: more on the boundary model. J Appl Soc Psychol 14:244–256
Kozlowski LT, Director J, Harford MA (1981) Tobacco dependence, restraint, and time to the first cigarette of the day. Addict Behav 6:307–312
Mackey CJ (1980) The measurement of mood and psychophysiological activity using self-report techniques. In: Martin I, Venables PH (eds), Techniques in psychophysiology. Wiley, New York, pp 501–562
McNair DM, Loor M, Droppelman LF (1971) Profile of mood states. Educational and Testing Service, San Diego, Calif.,
Morgan SF, Gust SW, Pickens RW, Champagne SE, Hughes JR (1985) Temporal patterns of smoking topography in the natural environment. Int J Addict 20:613–621
National Research Council (1986) Environmental tobacco smoke: measuring exposures and health effects. National Academy Press, Washington D.C.
Perkins KA, Epstein LH, Stiller R, Jennings JR, Christiansen C, McCarthy T (1986) An aerosol spray alternative to cigarette smoking in the study of the behavioral and physiological effects of nicotine. Behav Res Methods Instr Comput 18:420–426
Perkins KA, Epstein LH, Stiller RL, Marks BL, Jacob RG (1989) Chronic and acute tolerance to the heart rate effects of nicotine. Psychopharmacology 97:529–534
Perkins KA, Epstein LH, Stiller RL, Sexton JE, Debski T, Jacob RG (1990) Behavioral performance effects of nicotine in smokers and nonsmokers. Pharmacol Biochem Behav 37:11–15
Perkins KA, Grobe JE, Jennings JR, Epstein LH, Elash C (1992) A technique for rapid, reliable assessment of thermal pain threshold in humans. Behav Res Methods Instr Comput 24:60–66
Perkins KA, Grobe JE, Epstein LH, Caggiula AC, Stiller RL, Jacob RG (1993) Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav 45:375–381
Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA, Stiller RL, Scierka A, Jacob RG (1994a) Chronic and acute tolerance to subjective, behavioral, and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 27
Perkins KA, Grobe JE, Stiller RL, Scierka A, Goettler J, Reynolds WA, Jennings JR (1994b) Effects of nicotine on thermal pain detection in humans. Exper Clin Psychopharmacol 2:95–106
Pomerleau CS, Pomerleau OF (1992) Euphoriant effects of nicotine in smokers. Psychopharmacology 108:460–465
Porchet HC, Benowitz NL, Sheiner LB (1988) Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 244:231–236
Rosenberg J, Benowitz NL, Jacob P, Wilson KM (1980) Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 28:517–522
Russell MAH (1989) Subjective and behavioural effects of nicotine in humans: some sources of individual variation. Prog Brain Res 79:289–302
Sherwood N, Kerr JS, Hindmarch I (1992) Psychomotor performance in smokers following single and repeated doses of nicotine gum. Psychopharmacology 108:432–436
Shiffman S, Zettler-Segal M, Kassel J, Paty J, Benowitz NL, O'Brien G (1992) Nicotine elimination and tolerance in non-dependent cigarette smokers. Psychopharmacology 109:449–456
Stolerman IP, Fink R, Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacology 30:329–342
US Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction. A Report of the Surgeon General. US Government Printing Office, Washington D.C.
West RJ, Russell MAH (1987) Cardiovascular and subjective effects of smoking before and after 24 hr of abstinence from cigarettes. Psychopharmacology 92:118–121
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perkins, K.A., Grobe, J.E., Mitchell, S.L. et al. Acute tolerence to nicotine in smokers: lack of dissipation within 2 hours. Psychopharmacology 118, 164–170 (1995). https://doi.org/10.1007/BF02245835
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245835